CYCLOBENZAPRINE HYDROCHLORIDE
NDC 11788-095, Cyclobenzaprine Hydrochloride, tablet, film coated, from AiPing Pharmaceutical, Inc..
- Product NDC
- 11788-095
- Status
- Listed
- Labeler
- AiPing Pharmaceutical, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA072854
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11788-095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11788-095-01 | 11788009501 | 100 TABLET, FILM COATED in 1 BOTTLE (11788-095-01) |
| 11788-095-05 | 11788009505 | 500 TABLET, FILM COATED in 1 BOTTLE (11788-095-05) |
| 11788-095-10 | 11788009510 | 1000 TABLET, FILM COATED in 1 BOTTLE (11788-095-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11788-095 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11788-095 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11788-095. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.